Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment.

Park, Y H; Jung, H A; Choi, M K; Chang, W; Choi, Y L; Do, I-g; Ahn, J S; Im, Y-H

Park, Y H; Jung, H A; Choi, M K; Chang, W; Choi, Y L; Do, I-g; Ahn, J S; Im, Y-H.

Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi MK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chang W; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi YL; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Do IG; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Br J Cancer ; 110(2): 384-91, 2014 Jan 21.

Article en En | MEDLINE | ID: mdl-24346286

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/enzimología; Fosfohidrolasa PTEN/deficiencia; Receptor ErbB-2/genética; Receptor ErbB-3/biosíntesis; Adulto; Anciano; Anticuerpos Monoclonales Humanizados/administración & dosificación; Neoplasias de la Mama/genética; Hidrocarburos Aromáticos con Puentes/administración & dosificación; Supervivencia sin Enfermedad; Femenino; Humanos; Persona de Mediana Edad; Fosfohidrolasa PTEN/genética; Pronóstico; Receptor ErbB-3/genética; Estudios Retrospectivos; Taxoides/administración & dosificación; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Receptor ErbB-3 / Fosfohidrolasa PTEN Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google